A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation

References

• Bailey JM. Biochemistry and pharmacology of cyclooxygenase inhibitors. Bull NY Acad Med. 1989; 65:5–15.
   Google Scholar
• Talar-Williams C, Sneller MC. Complications of corticosteroid therapy. Eur Arch Otorhinolaryngol. 1994;251:131–136.
   PubMed Web of Science ®Google Scholar
• Carnahan MC, Goldstein DA. Ocular complications of topical, pen-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000; I I:478–483.
   Google Scholar
• Hugues FC, Le Jeunne C. Systemic and local tolerability of ophthalmic drug formulations. An update. Drug Saf 1993;8:365–380.
   Google Scholar
• McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002;25:33–55.
   Google Scholar
• Kara-Jose N, Lorenzetti DW, McAuliffe R, Conti T. Time response effects of corticosteroids on corneal wound healing. Can J Ophthalmol. 1972;7:48–51.
   Google Scholar
• McCarey BE, Napalkov JA, Pippen PA, Koester JM, al Reaves T. Corneal wound healing strength with topical antiinflammatory drugs. Cornea. 1995;14:29o–294.
   Google Scholar
• Ho PC, Elliott JH. Kinetics of corneal epithelial regeneration. II. Epidermal growth factor and topical corticosteroids. Invest Ophthalmol. 1975;14:630–633.
   PubMedGoogle Scholar
• Petroutsos G, Guimaraes R, Giraud JP, Pouliquen Y. Corticosteroids and corneal epithelial wound healing. Br J Ophthalmol. 1982;66:705–708.
   PubMed Web of Science ®Google Scholar
• Singh G. Corticosteroids in corneal endothelial wound healing. Ann Ophthalmol. 1985;17:238–243.
   PubMedGoogle Scholar
• Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984;68:329–331.
   PubMed Web of Science ®Google Scholar
• Martins JC, Wilensky JT, Asseff CF, Obstbaum SA, Buerk KM. Corticosteroid-induced uveitis. Am J Ophthalmol. 1974;77:433–437.
   PubMed Web of Science ®Google Scholar
• Krupin T, LeBlanc RP, Becker B, Kolker AE, Podos SM. Uveitis in association with topically administered corticosteroid. Am J Ophthalmol. 1970:70:883–885
   Google Scholar
• Newsome DA, Wong VG, Cameron TP, Anderson RR. 'Steroid-induced' mydriasis and ptosis. Invest Ophthalmol. 1971;10:424–429.
   Google Scholar
• Armaly ME Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration. Arch Ophthalmol. 1966;75:776–782.
   Google Scholar
• Armaly ME Becker B. Intraocular pressure response to topical corticosteroids. Fed PrOC. 1965;24: 1274–1278.
   Google Scholar
• Donshik PC, Cavanaugh HD, Boruchoff SA, Dohlman CH. Posterior subcapsular cataracts induced by topical corticosteroids following keratoplasty for keratoconus. Ann Ophthalmol. 1981;13:29–32.
   Google Scholar
• McGhee CN. Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol. 1992;76:681–684.
   PubMed Web of Science ®Google Scholar
• Vitale AM, Foster CS. Corticosteroids. In: Foster CS, Vitale AM, editors. Diagnosis and treatment of uveitis. Philadelphia: Harcourt, 2002; 142–158.
   Google Scholar
• Benet LZ, Mitchell JR, Sheiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: Goodman Gilman A, Ball TVV, Nies AS, Taylor P, editors. Goodman Gilman 's The pharmacological basis of therapeutics. 3rd ed. New York: Pergamon Press, 1990; 3–32.
   Google Scholar
• Haynes Jr RC. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of their synthesis and actions of adrenocortical hormones. In: Goodman Gilman A, Ball TW, Nies AS, Taylor P, editors. Goodman Gilman 's The pharmacological basis of therapeutics. 3rd ed. New York: Pergamon Press, 1990; 1431–1462.
   Google Scholar
• Worakul N, Unlu N, Robinson JR. Ocular pharmacokinetics. In: Abelson MB, Neufeld AH, Albert DM, Jakobiec FA, Azar DT, Gragoudas ES, editors. Principles and practice of ophthalmology. 2nd ed. Philadelphia: W.B. Saunders, 2000; 202–211.
   Google Scholar
• Reddy IK, Ganesan MG. Ocular therapeutics and drug delivery: an overview. In: Reddy IK, editor. Ocular therapeutics and drug delivery: a multi-disciplinary approach. Lancaster, PA: Technomic, 1996; 3–29.
   Google Scholar
• Lee V-HL, Robinso JR. Topical ocular drug delivery: recent developments and future challenges. J Ocular Pharmacol. 1986;2:67–108.
   Google Scholar
• Watsky MA, Jablonski M, Edelhauser HG. Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res. 1988;7:483–486.
   Google Scholar
• Cox WV, Kupferman A, Leibowitz HM. Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone. Arch Ophthalmol. 1972;88:308–313.
   Google Scholar
• Leibowitz HM, Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol. 1974;79:78–80.
   Google Scholar
• Krupin T, Waltman ST, Becker B. Ocular penetration in rabbits of topically applied dexamethasone. Arch Ophthalmol. 1974;92:312–314:
   Google Scholar
• Bodker FS, Ticho BH, Feist RM, Lam TT. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits. Ophthalmic Surg. 1993;24:453–457.
   Google Scholar
• Musson DG, Bidgood AM, Olejnik 0. Assay methodology for prednisolone, prednisolone acetate and prednisolone sodium phosphate in rabbit aqueous humor and ocular physiological solutions. J Chromatogr. 1991;565:89–102.
   Google Scholar
• Frey BM, Frey FJ. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1990;19:126–146.
   PubMed Web of Science ®Google Scholar
• Musson DG, Bidgood AM, Olejnik 0. An in vitro comparison of the permeability of prednisolone, prednisolone sodium phosphate, and prednisolone acetate across the NZW rabbit cornea. J Ocular Pharmacol. 1992;8:139–150.
   Google Scholar
• Smith RE, Nozik RA. Uveitis: a clinical approach to diagnosis and management. 2nd ed. Baltimore: Williams and Wilkins, 1989.
   Google Scholar
• Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: fundamentals and clinical practice. 2nd ed. St. Louis: Mosby, 1996.
   Google Scholar
• Cox WV, Kupferman A, Leibowitz HM. Topically applied steroids in corneal disease. II. The role of drug vehicle in stromal absorption of dexamethasone. Arch Ophthalmol. 1972;88:549–552.
   Google Scholar
• Kupferman A, Pratt MV, Suckewer K, Leibowitz HM. Topically applied steroids in corneal disease. 3. The role of drug derivative in stromal absorption of dexamethasone. Arch Ophthalmol. 1974;91:373–376.
   Google Scholar
• Kupferman A, Leibowitz HM. Topically applied steroids in corneal disease. IV. The role of drug concentration in stromal absorption of prednisolone acetate. Arch Ophthalmol. 1974;91:377–380.
   Google Scholar
• Kupferman A, Leibowitz HM. Topically applied steroids in corneal disease. V. Dexamethasone alcohol. Arch Ophthalmol. 1974;92:329–330.
   PubMed Web of Science ®Google Scholar
• Kupferman A, Leibowitz HM. Topically applied steroids in corneal disease. VI. Kinetics of prednisolone sodium phosphate. Arch Ophthalmol. 1974;92:331–334.
   Google Scholar
• Musson DG, Bidgood AM, Olejnik 0. Comparative corneal penetration of prednisolone sodium phosphate and prednisolone acetate in NZW rabbits. J Ocular Pharmacol. 1991;7:175–182.
   Google Scholar
• Kupferman A, Leibowitz HM. Penetration of fluorometholone into the cornea and aqueous humor. Arch Ophthalmol. 1975;93:425–427.
   PubMed Web of Science ®Google Scholar
• Kupferman A, Berrospi AR, Leibowitz HM. Fluorometholone acetate. A new ophthalmic derivative of fluorometholone. Arch Ophthalmol. 1982;I00:640–641.
   Google Scholar
• Yamauchi H, Kito H. Studies on intraocular penetration and metabolism of fluorometholone in rabbits: a comparison between dexamethasone and prednisolone acetate. Jpn J Ophthalmol. 1975;19:339–347:
   Google Scholar
• Olejnik O,Weisbecker CA. Ocular bioavailability of topical prednisolone preparations. Clin Ther. 1990;12:2—II.
   Google Scholar
• Leibowitz HM, Kupferman A. Anti-inflammatory effectiveness in the cornea of topically administered prednisolone. Invest Ophthalmol. 1974;13:757–763:
   PubMedGoogle Scholar
• Leibowitz HM, Kupferman A. Kinetics of topically administered prednisolone acetate. Optimal concentration for treatment of inflammatory keratitis. Arch Ophthalmol. 1976;94:1387–1389.
   Google Scholar
• Schoenwald RD, Boltralik JJ. A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthalmol Vis ScL 1979;18:61–66.
   PubMed Web of Science ®Google Scholar
• Kupferman A, Ryan W.T, Leibowitz HM. Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel. Arch Ophthalmol. 1981;99:2028–2029.
   Google Scholar
• Schoenwald RD, Steward P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci. 1980;69:391–394.
   PubMed Web of Science ®Google Scholar
• Bisrat M, Glazer M. Effect of particle size on ocular permeability of prednisolone acetate in rabbits. Acta Pharmacol Nord. 1992;4:5.
   PubMedGoogle Scholar
• Leibowitz HM, Kupferman A. Optimal frequency of topical prednisolone administration. Arch Ophthalmol. 1979;97:2154–2156.
   Google Scholar
• Fiscella RG, Jensen M, Van Dyck G. Generic prednisolone suspension substitution. Arch Ophthalmol. 1998;116:703.
   Google Scholar
• Burch PG, Migeon CJ. Systemic absorption of topical steroids. Arch Ophthalmol. 1968;79:174–176.
   PubMed Web of Science ®Google Scholar
• Krupin T, Mandell AT, Podos SM, Becker B. Topical corticosteroid therapy and pituitary-adrenal function. Arch Ophthalmol. 1976;94:919-92o.
   Google Scholar
• Romano PE, Traisman HS, Green OC. Fluorinated corticosteroid toxicity in infants. Am J Ophthalmol. 1977;84:247–250.
   Google Scholar
• Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an ii-year-old male with posterior uveitis. Am J Ophthalmol. 2000;130:240–241.
   PubMed Web of Science ®Google Scholar
• McGhee CN, Noble MI Watson DG, Dutton GN, Fern AT, Healey TM, Midgley JM. Penetration of topically applied prednisolone sodium phosphate into human aqueous humour. Eye. 1989;3:463–467.
   PubMed Web of Science ®Google Scholar
• McGhee CN, Watson DG, Midgley JM, Noble MI Dutton GN, Fern AT. Penetration of synthetic corticosteroids into human aqueous humour. Eye. 1990:4:526–530.
   Google Scholar
• Watson DG, McGhee CN, Midgley JM, Dutton GN, Noble MJ. Penetration of topically applied betamethasone sodium phosphate into human aqueous humour. Eye. 1990;4:603–606.
   Google Scholar
• Watson DG, Midgley JM, McGhee CN. The analysis of corticosteroid acetates by gas chromatography/ negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 1989;3:8–10.
   PubMed Web of Science ®Google Scholar
• Burde RM, Waltman SR. Topical corticosteroids after cataract surgery. Ann Ophthalmol. 1972;4: 290–293.
   PubMedGoogle Scholar
• Mustakallio A, Kaufman HE, Johnston G, Wilson RS, Roberts MD, Harter JC. Corticosteroid efficacy in postoperative uveitis. Ann Ophthalmol. 1973;5:719–730.
   Google Scholar
• Corboy JM. Corticosteroid therapy for the reduction of postoperative inflammation after cataract extraction. Am J Ophthalmol. 1976; 82:923–927.
   PubMed Web of Science ®Google Scholar
• Dunne JA, Travers JP. Double-blind clinical trial of topical steroids in anterior uveitis. Br J Ophthalmol. 1979;63:762–767.
   PubMed Web of Science ®Google Scholar
• Ramsell TG, Bartholomew RS, Walker SR. Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure. Br J Ophthalmol. 1980;64: 43–45.
   Google Scholar
• Stewart R, Horwitz B, Howes J, Novack GD, Hart K. Double-masked, placebo-controlled evaluation of loteprednol etabonate o.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1. J Cataract Refract Surg. 1998;24:148o–1489.
   Google Scholar
• Anonymous. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. Am J Ophthalmol. 1999;127:537–544.
   Google Scholar
• Foster CS, Alter G, DeBarge LR, Raizman MB, Crabb JL, Santos CI, Feiler LS, Friedlaender MH. Efficacy and safety of rimexolone % ophthalmic suspension vs u % prednisolone acetate in the treatment of uveitis. Am J Ophthalmol. 1996;122:171–182.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Ferris 3rd FL. New corticosteroids for the treatment of ocular inflammation. Am J Ophthalmol. 1999;127:597–599.
   Google Scholar
• Elliot AJ. Recurrent intraocular hemorrhage in young adults (Eales' disease). Arch Ophthalmol. 1959;61: 745–754.
   Google Scholar
• Nozik RA. Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol. 1972;76: 694–703.
   Google Scholar
• Hyndiuk RA. Radioactive depot-corticosteroid penetration into monkey ocular tissue. II. Subconjunctival administration. Arch Ophthalmol. 1969;82:259–263.
   Google Scholar
• Weijtens 0, Schoemaker RC, Cohen AF, Romijn FP, Lentjes EG, van Rooij J, van Meurs JC. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol. 1998;125:673–679.
   Google Scholar
• Weijtens 0, Feron EJ, Schoemaker RC, Cohen AF, Lentjes EG, Romijn FP, van Meurs JC. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128:192–197.
   Google Scholar
• Weijtens 0, van der Sluijs FA, Schoemaker RC, Lentjes EG, Cohen AF, Romijn FP, van Meurs JC. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123: 358–363.
   Google Scholar
• Weijtens 0, Schoemaker RC, Lentjes EG, Romijn FP, Cohen AF, van Meurs JC. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology. 2000;107: 1932–1938.
   Google Scholar
• Kunou N, Ogura Y, Honda Y, Hyon SH, Ikada Y. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. J Biomed Mater Res. 2000;51:635–641.
   Google Scholar
• McCartney HJ, Drysdale JO, Gornall AG, Basu PK. An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into the normal and inflamed rabbit eye. Invest Ophthalmol. 1965;76:297–302.
   Google Scholar
• Wine NA, Gornall AG, Basu PK. The ocular uptake of subconjunctivally injected C14 hydrocortisone. Am J Ophthalmol. 1964;58: 362–366.
   Google Scholar
• Hakin KN, Ham J, Lightman SL. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol. 1991;75:337–339.
   Google Scholar
• Gebertt S. Depot-methylprednisolone for subconjunctival and retrobulbar injection. Lancet. 1961;2:344–345.
   PubMedGoogle Scholar
• Rodger FC. Repository corticotherapy in ophthalmic theory and practice. Br J Ophthalmol. 1965;49:298–306.
   Google Scholar
• Schlaegel Jr TF, Weber JC. Treatment of pars planitis. II. Corticosteroids. Surv Ophthalmol. 1977;22:120,125–130.
   Google Scholar
• Riordan-Eva P, Lightman S. Orbital floor steroid injections in the treatment of uveitis. Eye. 1994;8: 66–69.
   Google Scholar
• Lightman S. Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye. 1991;5:294–298.
   PubMedGoogle Scholar
• Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye. 1998;12:679–685.
   Google Scholar
• Walton RC, Vick VL, Greenwald MA. Sub-tenon's corticosteroids for the treatment of macular edema in bone marrow transplant retinopathy. Retina. 1999;19: 171–173.
   Google Scholar
• Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55–64.
   PubMed Web of Science ®Google Scholar
• Sajnani D. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye. 1999;13: 703–704.
   PubMedGoogle Scholar
• Kalina PH, Erie JC, Rosenbaum L. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995;113: 867–869.
   PubMedGoogle Scholar
• Francis BA, Chang EL, Haik BG. Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice. Ophthalmology. 1996;103:1884–1888.
   Google Scholar
• Hyndiuk RA, Reagan MG. Radioactive depot-corticosteroid penetration into monkey ocular tissue. I. Retrobulbar and systemic administration. Arch Ophthalmol. 1968;80:499–503.
   PubMed Web of Science ®Google Scholar
• Levine ND, Aronson SB. Orbital infusion of steroids in the rabbit. Arch Ophthalmol. 1970;83:599–607.
   PubMedGoogle Scholar
• Jennings T, Rusin MM, Tessler HH, Cunha-vaz JG. Posterior sub-tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1988;32:385–391.
   Google Scholar
• Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997;104:2003–2008.
   Google Scholar
• Freeman WR, Green RI, Smith RE. Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol. 1987; 103:281–288.
   Google Scholar
• Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis ScL 1995;36:1893–1903.
   PubMed Web of Science ®Google Scholar
• Morgan CM, Schatz H, Vine AK, Cantrill HL, Davidorf FH, Gitter KA, Rudich R. Ocular complications associated with retrobulbar injections. Ophthalmology. 1988;95:660–665.
   Google Scholar
• Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis ScL 2000;41:3569–3575.
   PubMed Web of Science ®Google Scholar
• Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol. 1976;82:90–93.
   PubMed Web of Science ®Google Scholar
• Levin DS, Han DP, Dev S, Wirostko WJ, Mieler WF, Connor TB, George V, Eastwood D. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am J Ophthalmol. 2002; 133:196–202.
   Google Scholar
• Mueller AJ, Jian G, Banker AS, Rahhal FM, Capparelli E, Freeman WR. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol. 1998; 125:158–163.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Herbst R. Bacterial endophthalmitis. Treatment with intraocular injection of gentamicin and dexamethasone. Arch Ophthalmol. 1974;91:416–418.
   Google Scholar
• Graham RO, Peyman GA. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol. 1974;92:149–154.
   Google Scholar
• Maxwell Jr DP, Brent BD, Diamond JG, Wu L. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis [see comments]. Ophthalmology. 1991;98:1370–1375.
   Google Scholar
• Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol. 1999;82:1050–1055.
   Google Scholar
• Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo CD, Brown GC, Tasman W Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology. 2000;107:486–489.
   PubMed Web of Science ®Google Scholar
• Majji AB, Jalali S, Das T, Gopinathan U. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye. 1999;13:660–665.
   PubMed Web of Science ®Google Scholar
• Anonymous. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group [see comments]. Arch Ophthalmol. 1995; 113:1479–1496.
   Google Scholar
• Benitez Del Castillo Sanchez JM, Garcia Sanchez J. [Intravitreal injection of triamcinolone acetonide in non infectious uveitis]. Arch Soc Esp Oftalmol. 2001;76:661–664.
   Google Scholar
• Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107:2024–2033 .
   PubMed Web of Science ®Google Scholar
• Tan DT, Chee SP, Lim L, Theng J, Van Ede M. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye. Ophthalmology. 200 I; I 08:2 I 72-218 I .
   Google Scholar
• Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 1999;106:223–231.
   PubMed Web of Science ®Google Scholar
• Chang DF, Wong V. Two clinical trials of an intraocular steroid delivery system for cataract surgery. Trans Am Ophthalmol Soc. 1999;97:261-274 discussion 274–279.
   Google Scholar
• Jaffe GJ, Pearson PA, Ashton P. Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. Retina. 2000;20: 402–403.
   Google Scholar
• Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;mi:190–195.
   Google Scholar
• Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29: 2–6.
   PubMed Web of Science ®Google Scholar
• Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108:765–772.
   PubMed Web of Science ®Google Scholar
• Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380–1383.
   Google Scholar
• Schindler RH, Chandler D, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol. 1982;93:415–417.
   PubMed Web of Science ®Google Scholar
• Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection [see comments]. Arch Ophthalmol. 1992;110:259–266.
   PubMed Web of Science ®Google Scholar
• Woods AC. Clinical and experimental observations on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol. 1950;33:1325–1149.
   Google Scholar
• Gordon DM. Prednisone and prednisolone in ocular disease. Am J Ophthalmol. 1956;41:593–600.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Cunningham ET Jr. Use of corticosteroids and noncorticosteroid immunosuppressive agents in patients with uveitis. Compr Ophthalmol Update. 2000;1: 273–286.
   Google Scholar
• Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847–851.
   Google Scholar
• McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105: 793–797.
   PubMedGoogle Scholar
• Hill JC, Maske R, Watson PG. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection: a preliminary report. Eye. 1991;5: 420–424.
   Google Scholar
• Behar-Cohen FF, Gauthier S, El Aouni A, Chapon P, Parel JM, Renard G, Chauvaud D. Methylprednisolone concentrations in the vitreous and the serum after pulse therapy. Retina. 2001;21:48–53.
   Google Scholar
• Kroman HS, Leopold IL. Studies upon methyl- and fluorosubstituted prednisolones in the aqueous humor of rabbit. Am J Ophthalmol. 1960;52:77–81.
   Google Scholar
• Stanbury R, Graham E. Systemic corticosteroid therapy: side effects and their management. Br J Ophthalmol. 1998;82:704–708.
   PubMed Web of Science ®Google Scholar